Advertisement
Screener

Applied Therapeutics, Inc. Share-based Payment Arrangement, Expense

Applied Therapeutics, Inc. Share-based Payment Arrangement, Expense

Applied Therapeutics, Inc. reported Share-based Payment Arrangement, Expense of $1.14 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2025-11-13

  • Applied Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $1.14M, a 45.43% decline year-over-year.
  • Applied Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2025-06-30 was $2.10M, a 11.11% increase year-over-year.
  • Applied Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2025-03-31 was $1.49M, a 37.49% decline year-over-year.
  • Applied Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2024-12-31 was $9.21M, a 466.24% increase year-over-year.
  • Applied Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2024 was $15.57M, a 111.51% increase from fiscal 2023.
  • Applied Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2023 was $7.36M, a 23.36% decline from fiscal 2022.
  • Applied Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2022 was $9.60M, a 14.08% decline from fiscal 2021.
  • Applied Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2021 was $11.18M, a 39.26% increase from fiscal 2020.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 3 month as first filedShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 6 month as first filedShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 12 monthShare-based Payment Arrangement, Expense 12 month as first filed
2025-09-30$1.14M
10-Q · filed 2025-11-13
$3.24M
derived: sum of 2 quarters · filed 2025-11-13
$4.73M
10-Q · filed 2025-11-13
$13.94M
derived: sum of 4 quarters · filed 2025-11-13
2025-06-30$2.10M
10-Q · filed 2025-08-13
$3.59M
10-Q · filed 2025-08-13
$12.79M
derived: sum of 3 quarters · filed 2025-08-13
$14.88M
derived: sum of 4 quarters · filed 2025-11-13
2025-03-31$1.49M
10-Q · filed 2025-05-14
$10.69M
derived: sum of 2 quarters · filed 2025-05-14
$12.79M
derived: sum of 3 quarters · filed 2025-11-13
$14.68M
derived: sum of 4 quarters · filed 2025-11-13
2024-12-31$9.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15
$11.30M
derived: sum of 2 quarters · filed 2025-11-13
$13.19M
derived: sum of 3 quarters · filed 2025-11-13
$15.57M
10-K · filed 2025-04-15
2024-09-30$2.09M
10-Q · filed 2025-11-13
$3.98M
derived: sum of 2 quarters · filed 2025-11-13
$6.36M
10-Q · filed 2025-11-13
$7.99M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$1.89M
10-Q · filed 2025-08-13
$4.27M
10-Q · filed 2025-08-13
$5.89M
derived: sum of 3 quarters · filed 2025-08-13
$7.73M
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31$2.38M
10-Q · filed 2025-05-14
$4.00M
derived: sum of 2 quarters · filed 2025-05-14
$5.84M
derived: sum of 3 quarters · filed 2025-05-14
$7.68M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$1.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15
$3.46M
derived: sum of 2 quarters · filed 2025-04-15
$5.30M
derived: sum of 3 quarters · filed 2025-04-15
$7.36M
10-K · filed 2025-04-15
2023-09-30$1.84M
10-Q · filed 2024-11-07
$3.68M
derived: sum of 2 quarters · filed 2024-11-07
$5.73M
10-Q · filed 2024-11-07
$8.17M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$1.84M
10-Q · filed 2024-08-07
$3.90M
10-Q · filed 2024-08-07
$6.34M
derived: sum of 3 quarters · filed 2024-08-07
$9.19M
derived: sum of 4 quarters · filed 2024-08-07
2023-03-31$2.06M
10-Q · filed 2024-05-09
$4.49M
derived: sum of 2 quarters · filed 2024-05-09
$7.35M
derived: sum of 3 quarters · filed 2024-05-09
$9.58M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$2.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06
$5.29M
derived: sum of 2 quarters · filed 2024-03-06
$7.53M
derived: sum of 3 quarters · filed 2024-03-06
$9.60M
10-K · filed 2024-03-06
$9.16M
10-K · filed 2023-03-23
2022-09-30$2.86M
10-Q · filed 2023-11-09
$5.09M
derived: sum of 2 quarters · filed 2023-11-09
$7.16M
10-Q · filed 2023-11-09
$10.01M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$2.23M
10-Q · filed 2023-08-10
$4.31M
10-Q · filed 2023-08-10
$7.16M
derived: sum of 3 quarters · filed 2023-08-10
$9.80M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$2.08M
10-Q · filed 2023-05-11
$4.93M
derived: sum of 2 quarters · filed 2023-05-11
$7.57M
derived: sum of 3 quarters · filed 2023-05-11
$10.27M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$2.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
$5.49M
derived: sum of 2 quarters · filed 2023-03-23
$8.20M
derived: sum of 3 quarters · filed 2023-03-23
$11.18M
10-K · filed 2023-03-23
2021-09-30$2.65M
10-Q · filed 2022-11-09
$5.35M
derived: sum of 2 quarters · filed 2022-11-09
$8.33M
10-Q · filed 2022-11-09
$10.88M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$2.70M
10-Q · filed 2022-08-12
$5.68M
10-Q · filed 2022-08-12
$8.24M
derived: sum of 3 quarters · filed 2022-08-12
$10.64M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$2.98M
10-Q · filed 2022-05-12
$5.54M
derived: sum of 2 quarters · filed 2022-05-12
$7.94M
derived: sum of 3 quarters · filed 2022-05-12
$9.51M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$2.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
$4.96M
derived: sum of 2 quarters · filed 2022-03-10
$6.53M
derived: sum of 3 quarters · filed 2022-03-10
$8.03M
10-K · filed 2022-03-10
2020-09-30$2.40M
10-Q · filed 2021-11-12
$3.98M
derived: sum of 2 quarters · filed 2021-11-12
$5.47M
10-Q · filed 2021-11-12
$6.66M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$1.57M
10-Q · filed 2021-08-12
$2.89M
10-Q · filed 2021-08-12
$2.88M
10-Q · filed 2020-08-11
$4.25M
derived: sum of 3 quarters · filed 2021-08-12
$5.47M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$1.33M
10-Q · filed 2021-05-11
$1.31M
10-Q · filed 2020-05-11
$2.68M
derived: sum of 2 quarters · filed 2021-05-11
$3.90M
derived: sum of 3 quarters · filed 2021-05-11
$7.18M
derived: sum of 4 quarters · filed 2021-05-11
2019-12-31$1.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18
$2.57M
derived: sum of 2 quarters · filed 2021-03-18
$5.85M
derived: sum of 3 quarters · filed 2021-03-18
$6.17M
10-K · filed 2021-03-18
2019-09-30$1.22M
10-Q · filed 2020-11-12
$1.22M
10-Q · filed 2019-11-13
$4.50M
derived: sum of 2 quarters · filed 2020-11-12
$4.82M
10-Q · filed 2020-11-12
$4.92M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$3.28M
10-Q · filed 2020-08-11
$3.60M
10-Q · filed 2020-08-11
$3.69M
derived: sum of 3 quarters · filed 2020-08-11
$3.77M
derived: sum of 4 quarters · filed 2020-08-11
2019-03-31$325.00K
10-Q · filed 2020-05-11
$417.00K
derived: sum of 2 quarters · filed 2020-05-11
$495.00K
derived: sum of 3 quarters · filed 2020-05-11
$571.00K
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31$92.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
$170.00K
derived: sum of 2 quarters · filed 2020-03-13
$246.00K
derived: sum of 3 quarters · filed 2020-03-13
$272.00K
10-K · filed 2020-03-13
2018-09-30$78.00K
10-Q · filed 2019-11-13
$154.00K
derived: sum of 2 quarters · filed 2019-11-13
$180.00K
10-Q · filed 2019-11-13
2018-06-30$76.00K
10-Q · filed 2019-08-12
$103.00K
10-Q · filed 2019-08-12
2018-03-31$26.00K
10-Q · filed 2019-06-21